SciELO - Scientific Electronic Library Online

 
vol.72 número5Pharmacogenomics: Current Actionable Variants índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista de investigación clínica

versión On-line ISSN 2564-8896versión impresa ISSN 0034-8376

Resumen

GONZALEZ-DUARTE, Alejandra; KAUFER-HORWITZ, Martha  y  AGUILAR-SALINAS, Carlos A.. Bioethics in the COVID-19 Pandemic Research: Challenges and Strategies. Rev. invest. clín. [online]. 2020, vol.72, n.5, pp.265-270.  Epub 09-Abr-2021. ISSN 2564-8896.  https://doi.org/10.24875/ric.20000258.

As all other aspects in times of the coronavirus disease (COVID)-19 pandemic, carrying-out quality clinical research has been challenging. Many well-established paradigms have shifted as a consequence of the rapid demand for new knowledge. New treatments are fast-moving, informed consent forms are difficult to obtain, a competitive invitation from researchers to participate in different studies is common, and non-COVID-19 research protocols are suffering continuity. However, these challenges should not imply taking shortcuts or accepting deficiencies in bioethical standards, but rather enhance the alertness for rigorous ethical approaches despite these less than ideal circumstances. In this manuscript, we point out some interrogates in COVID-19 research and outline possible strategies to overcome the difficult task to continue with high-quality research without violating the ethical principles. (REV INVEST CLIN. 2020;72(5):265-70)

Palabras llave : Coronavirus disease-19; Informed Consent; Research Ethics Committees; Ethics.

        · texto en Inglés     · Inglés ( pdf )